Regulation of cyclooxygenase-2 pathway by HER2 receptor - PubMed (original) (raw)
. 1999 Jan 14;18(2):305-14.
doi: 10.1038/sj.onc.1202307.
Affiliations
- PMID: 9927187
- DOI: 10.1038/sj.onc.1202307
Regulation of cyclooxygenase-2 pathway by HER2 receptor
R Vadlamudi et al. Oncogene. 1999.
Abstract
Emerging lines of evidence suggest that in addition to growth factors, the process of colorectal tumorigenesis may also be driven by the upregulation of the inducible form of cyclooxygenase-2 (COX-2), an enzyme responsible for the conversion of arachidonic acid to PGEs. The present study was undertaken to investigate the expression and activation of the HER family members, and to explore the regulation of COX-2 expression by the HER2 pathway in human colorectal cancer cells. Here, we report that human colorectal cancer cell lines express abundant levels of HER2 and HER3 receptors, and are growth-stimulated by recombinant neu-differentiation factor-beta 1 (NDF). NDF-treatment of colorectal cancer cells was accompanied by increased tyrosine phosphorylation and heterodimerization of HER3 with HER2. In addition, we demonstrated that HER2 and HER3 receptors in colorectal cancer cells are constitutively phosphorylated on tyrosine residues and form heterodimeric complexes in the absence of exogenous NDF. Inhibition of HER2/HER3 signaling by an anti-HER3 mAb against the ligand binding site resulted in a decrease in the levels of constitutively activated HER2/ HER3 heterodimers, and the unexpected reduction of COX-2 expression. Activation of the HER2/HER3 pathway by NDF induced the activation of COX-2 promoter, expression of COX-2 mRNA, COX-2 protein and accumulation of prostaglandin E2 in the culture medium. Finally, we demonstrated that NDF promotes the ability of colorectal cancer cells to survive in an extracellular matrix milieu, such as Matrigel, and also to invade through a 8 microm porous membrane. These biological activities of NDF and its stimulation of cell proliferation are blocked by a specific inhibitor of COX-2. Taken together, our findings provide the first biochemical evidence of a possible role of the COX-2 pathway in the mitogenic action of NDF in colorectal cancer cells where it may be constitutively upregulated due to the autocrine/paracrine activation of HER2/ HER3 heterodimers.
Similar articles
- EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells.
Shimizu M, Deguchi A, Joe AK, Mckoy JF, Moriwaki H, Weinstein IB. Shimizu M, et al. J Exp Ther Oncol. 2005;5(1):69-78. J Exp Ther Oncol. 2005. PMID: 16416603 - ErbB kinases and NDF signaling in human prostate cancer cells.
Grasso AW, Wen D, Miller CM, Rhim JS, Pretlow TG, Kung HJ. Grasso AW, et al. Oncogene. 1997 Nov 27;15(22):2705-16. doi: 10.1038/sj.onc.1201447. Oncogene. 1997. PMID: 9400997 - [COX-2 inhibitor and colon cancer].
Tsujii M. Tsujii M. Gan To Kagaku Ryoho. 2001 Nov;28(12):1799-805. Gan To Kagaku Ryoho. 2001. PMID: 11729471 Review. Japanese. - The upgraded role of HER3 and HER4 receptors in breast cancer.
Koutras AK, Fountzilas G, Kalogeras KT, Starakis I, Iconomou G, Kalofonos HP. Koutras AK, et al. Crit Rev Oncol Hematol. 2010 May;74(2):73-8. doi: 10.1016/j.critrevonc.2009.04.011. Epub 2009 May 30. Crit Rev Oncol Hematol. 2010. PMID: 19481955 Review.
Cited by
- Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigen receptor (CAR) for tumor immunotherapy; recent progress.
Budi HS, Ahmad FN, Achmad H, Ansari MJ, Mikhailova MV, Suksatan W, Chupradit S, Shomali N, Marofi F. Budi HS, et al. Stem Cell Res Ther. 2022 Jan 29;13(1):40. doi: 10.1186/s13287-022-02719-0. Stem Cell Res Ther. 2022. PMID: 35093187 Free PMC article. Review. - Anti-Inflammatory and Anticancer Properties of Birch Bark-Derived Betulin: Recent Developments.
Tuli HS, Sak K, Gupta DS, Kaur G, Aggarwal D, Chaturvedi Parashar N, Choudhary R, Yerer MB, Kaur J, Kumar M, Garg VK, Sethi G. Tuli HS, et al. Plants (Basel). 2021 Dec 3;10(12):2663. doi: 10.3390/plants10122663. Plants (Basel). 2021. PMID: 34961132 Free PMC article. Review. - Preparation and Characterization of MUC-30-Loaded Polymeric Micelles against MCF-7 Cell Lines Using Molecular Docking Methods and In Vitro Study.
Nasongkla N, Tuchinda P, Munyoo B, Eawsakul K. Nasongkla N, et al. Evid Based Complement Alternat Med. 2021 May 28;2021:5597681. doi: 10.1155/2021/5597681. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34135981 Free PMC article. - Anti-cancer effects of Bifidobacterium species in colon cancer cells and a mouse model of carcinogenesis.
Asadollahi P, Ghanavati R, Rohani M, Razavi S, Esghaei M, Talebi M. Asadollahi P, et al. PLoS One. 2020 May 13;15(5):e0232930. doi: 10.1371/journal.pone.0232930. eCollection 2020. PLoS One. 2020. PMID: 32401801 Free PMC article. - Alterations of COX-2, HER-2/neu and E-Cadherin protein expression in the prostatic adenocarcinoma: preliminary findings.
Musalam A, Andarawi M, Osman M, Al-Shriam M, Elrefaie A, Mahfouz AA, Hussein MA. Musalam A, et al. Am J Transl Res. 2019 Mar 15;11(3):1653-1667. eCollection 2019. Am J Transl Res. 2019. PMID: 30972191 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous